v1
Abstract 1986: RAS signaling is the key factor determining differential response to PI3K and MAPK targeting compounds in a panel of breast cancer cell lines
NobleIDNI4P48W54R66S75
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260521/CF4960CD)
ARK Inflections
Metadata Formats
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →